Aerobic and dynamic resistance exercises could exert a slight hypoalgesic effect on experimental pain, reports a new meta-analysis. The literature around this subject, however, is sparse, and further studies are needed, particularly those looking at patients with chronic musculoskeletal pain.
Fructose intake by mothers during early lactation can negatively impact infant neurodevelopmental outcomes at 24 postnatal months, and this is potentially caused by consumption of sugar-sweetened beverage (SSB) and juice (J), suggests a study.
Some patients with chronic kidney disease (CKD) develop cognitive impairment, with risk factors including previous stroke, depression or anxiety, higher proteinuria, and prescription of psychodynamic medications, a study reports.
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa,
08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
Spending too much time sitting cannot be good for the body, and rising to one's feet breaks up such a behaviour and yields small, but meaningful, reductions in certain cardiovascular disease (CVD) risk factors, according to the results of a meta-analysis.
Use of thyroid hormone therapy does not seem to protect older adults with subclinical hypothyroidism against mortality, but it appears to confer survival benefits to those aged <65 years, results of a study have shown.